SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing significant downward pressure as investors rotate out of precious metals due to a stronger dollar, rising Treasury yields, and persistent inflation concerns following the U.S.-Iran conflict. The community is actively debating whether this decline represents a major liquidity-driven capitulation or a temporary pullback, with many participants split between aggressively buying the dip for long-term protection against debt and stagflation, or exiting positions amid heightened market volatility.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer Inc. is experiencing extreme volatility and intense community debate following a federal indictment alleging that a co-founder and employees engaged in a multi-billion dollar scheme to smuggle AI servers to China. While bulls emphasize that the company itself was not named as a defendant and point to its strong revenue growth as a buying opportunity, bears and skeptical investors argue that the management's involvement in a national security breach creates irreparable reputational damage and threatens future partnerships with key players like Nvidia.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPY is experiencing significant volatility as investors weigh the impact of an escalating geopolitical standoff in the Strait of Hormuz against the potential for an impending peace deal. Community sentiment is deeply fractured, with bears highlighting recession risks and inflationary pressures, while bulls and contrarians are closely monitoring the market for signs of a technical bounce or a larger squeeze.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. (ANNA) is surging as geopolitical instability in the Middle East triggers significant supply shocks in the global liquefied natural gas market. Investors are closely monitoring the stock due to its strategic positioning in Italian natural gas assets and high trading volume, fueling active community debate regarding potential short-squeeze dynamics and the impact of the unfolding energy crisis.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors react to a combination of geopolitical instability, shifting macro-economic signals, and a federal jury ruling that Musk misled investors during the 2022 Twitter acquisition. The community is sharply divided, with bulls pointing to the potential long-term value of the new Terafab chip initiative and robotics, while bears are aggressively highlighting deteriorating sales, regulatory investigations, and the risk that the stock is caught in a broader market correction.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors await a critical Supreme Court decision regarding patent infringement that could reshape 'skinny label' drug regulations. Meanwhile, community sentiment is heavily focused on the company's recent move toward profitability and anticipation that its cash-positive position and intellectual property might attract potential acquisition interest during the J.P. Morgan Healthcare Conference.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is experiencing heightened volatility as the market reacts to a 48-hour ultimatum issued by the U.S. government regarding the Strait of Hormuz. The investor community is actively debating the geopolitical risks, potential for an energy sector shock, and the broader implications for the 401k-heavy tech sector as traders weigh the credibility of these evolving threats against recent market overselling.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is capturing significant market attention following a high-profile feature on '60 Minutes' that highlighted the company's strategic importance in securing U.S. rare earth supply chains. Investors and community members are actively debating the stock's role in national security and the broader rare earth supercycle as the company transitions into a fully integrated manufacturer.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is seeing high volatility as traders react to shifting weather models, ongoing Middle East geopolitical tensions, and uncertainty regarding natural gas storage levels. The community is actively debating the impact of potential supply disruptions in the Strait of Hormuz versus bearish seasonal trends as the market approaches the spring shoulder season.

AABG Token

AABBG is trending as shareholders rally around the anticipation of the new AABB Wallet launch and the debut of the silver-backed AABBS token, while maintaining high conviction in their legal battle against market makers for alleged price manipulation. The community remains focused on the company's reported gold and silver stockpiles, with many long-term investors actively accumulating shares and discussing the potential for a significant short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Micro Cap Biotech Secures $60M to Advance Alzheimer’s Treatment, Shares Surge

Alzheimer&#8217;s disease is the most common form of dementia, primarily affecting people over the age of 65. It progressively damages brain cells through the buildup of abnormal proteins (known as plaques and tangles) which destroy neurons and interfere with communication throughout the brain.Developing effective prevention or treatment remains extremely challenging because Alzheimer&#8217;s is driven by multiple interacting factors, including inflammation, genetics, and possibly infections, rather than a single cause. In addition, many therapies struggle to reach the brain due to its ...

Clinical stage biotech company Vaccinex’s ($VCNX) stock was up nearly 16% (1:54 pm ET) on Thursday afternoon after the company said it will provide an update on safety and efficacy data from its Alzheimer’s drug study, lifting retail sentiment.Rochester, N.Y.-based Vaccinex said it will present ‘promising’ new efficacy and safety data for a randomized, double-blind, phase 1b/2 SIGNAL-AD study for the treatment of Alzheimer’s disease. Its lead product candidate is related to studying pepinemab antibody, aimed at treating early stages of Alzheimer’s disease. The company’s last update on positive clinical findings from its SIGNAL-AD Phase 1b/2 trial were made in August.VCNX stock is up 19.53% this week.Retail sentiment on the stock turned ‘bullish’ (72/100) from ‘neutral’ (50/100) a week ago with message volumes climbing into the ‘high’ zone compared to ‘normal’ last week.<figure class="image"><img style="aspect-ratio:1308/370;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_24_at_10_54_58_PM_16e50ec661.png" alt="Screenshot 2024-10-24 at 10.54.58 PM.png" width="1308" height="370"><figcaption>VCNX sentiment meter as of 1:25 pm ET</figcaption></figure>Many Stocktwits users were optimistic about its prospects even though the company has faced headwinds this year due to a challenging macro environment for biotech companies.<stembedurl>https://stocktwits.com/Pbonk/message/590003737</stembedurl><stembedurl>https://stocktwits.com/Krystian_v/message/589974260</stembedurl>As on December 31, 2023, the company’s cash and cash equivalents and marketable securities stood at $1.5 million, down from $6.4 million as of Dec. 31, 2022. In Oct. 2023, the company raised $9.6 million from the sale of common stock and warrants.VCNX stock is down 71% year-to-date.For updates and corrections, email newsroom@stocktwits.com&nbsp;

Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens

The Rochester, N.Y.-based firm said it will present ‘promising’ new efficacy and safety data for the treatment of Alzheimer’s disease later this month.

Vaccinex Stock Spikes On Promising Data On Alzheimer’s Drug Study: Retail Sentiment Brightens

Equity

Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in April 2001 and is headquartered in Rochester, NY.

VCNX
Vaccinex Inc

Feed

News

Sentiment

Fundamentals

Info

Latest VCNX News

VCNXVaccinex Inc